Voices Against Brain Cancer, an organization dedicated to brain cancer research and advocacy, comments on a breakthrough brain surgery that gives neurosurgeons access to brain tumors, abscesses, and hemorrhages embedded deep in the brain.
As a part of the transaction, Univa acquired Oracle Grid Engine assets and intellectual property making it the sole commercial provider of Grid Engine.
River Cities has announced that its portfolio company Horizon Resource Group (HRG) has been acquired by Provista, a leading supply chain improvement company and subsidiary of Novation, one of the largest healthcare GPOs (group purchasing organizations) in the country.
An expanded global footprint with orthopedic device OEMs will further enhance MedPlast’s medical business segment.
Trax Technologies, a Scottsdale-based company that delivers logistics settlement services to global shippers and transportation carriers, has appointed Gregory W. Vesper to the role of chief product officer.
David A. MannReporter- Business First If the problem in health care is rising costs, then what is the solution? That question bounced around the room as I sat in on a panel discussion on health care this morning at the Mid-South ACG Capital Connection conference in Louisville. Davis Griffin, a venture partner at Cincinnati-based River […]
TissueTech, Inc., the industry leader in regenerative tissue engineering, announced the completion of a $10 million round of growth equity financing from Ballast Point Ventures and River Cities Capital Funds.
Brad Fluegel brings integrated care vision and healthcare business strategy to innovative healthcare management company board.
StepLeader, an innovative mobile app developer and advertisement platform, recently received an investment from one of North Carolina Innovation Fund’s (NCIF) private equity managers, River Cities Capital Funds (River Cities).
ABT Molecular Imaging, Inc., in Knoxville, TN, has successfully achieved the installation and clinical use of its next-generation Biomarker Generator by the Sveta Marina University Hospital in Bulgaria. ABT’s next-generation product integrates a compact accelerator and micro-chemistry with integrated quality control, for single-dose biomarker production.